All manuscripts submitted to Cancer Drug Resistance undergo single blind peer review. All manuscripts are reviewed initially by a journal editor. Then, the journal editor passes submitted manuscripts to the Editor-in-Chief. Depending on the research field of this manuscript, Editor-in-Chief sends it to Associate Editor or Editorial Board Member in this field. Then the assigned Associate Editor or Editorial Board Member will invite peer reviewers. Peer reviewers will give comments and recommendation. Peer reviewers comments plus the assigned Associate Editor or Editorial Board Member’s comments will be returned to authors. After authors’ revision, the final decision will be made by Editor-in-Chief.